or Try an Advanced Search...

    Pharmaceuticals Segment Stocks List

    Symbol Grade Name % Change
    NVO B Novo Nordisk A/S -2.18
    PRGO A Perrigo Company -0.09
    XPH D SPDR S&P Pharmaceuticals ETF 1.19
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Diabetes Diabetes Care Hormones Pharmaceutical Products Active Pharmaceutical Ingredients Allergy Analgesics Animal Health Anti Diabetic Drugs Biopharmaceutical Cough Dietary Supplement ETF Endocrine System Exchange Traded Fund Feminine Hygiene Gastrointestinal Generic Drug Glucagon Like Peptide 1 Growth Hormone

    Related ETFs - A few ETFs which own one or more of the above listed Pharmaceuticals Segment stocks.

    Symbol Grade Name Weight
    EDEN A iShares MSCI Denmark Capped ETF 23.21
    PPH B Market Vectors Pharmaceutical ETF 10.46
    IGTR C Innovator Gradient Tactical Rotation Strategy ETF 8.1
    PJIO D PGIM Jennison International Opportunities ETF 7.68
    AADR A WCM BNY Mellon Focused Growth ADR ETF 6.56
    View all Pharmaceuticals Segment ETFs...
    Compare ETFs
    Compare EDEN to IGTR Compare IGTR to AADR Compare PJIO to AADR

        Pharmaceuticals Segment Stocks Recent News

        Date Stock Title
        May 2 NVO Demand Soars For Novo Nordisk's Weight-Loss Drug Wegovy Despite Supply Constraints And Eli Lilly Competition
        May 2 NVO UPDATE 3-Novo Nordisk raises outlook fuelled by obesity drug demand
        May 2 NVO Novo Nordisk GAAP EPADR of DKK 5.68, revenue of DKK 65.35B; updates FY24 outlook
        May 2 NVO Novo Nordisk raises outlook fuelled by obesity drug demand
        May 2 NVO Novo Nordisk's sales increased by 22% in Danish kroner and by 24% at constant exchange rates to DKK 65.3 billion in the first three months of 2024
        May 2 NVO FOCUS-British pharmacies vie for weight-loss patients with drug price cuts
        May 2 NVO Dow Jones Futures Rise, Carvana Skyrockets; Stock Market Erases Fed Gains
        May 1 NVO Apple, Novo Nordisk earnings, jobless claims: What to watch
        May 1 NVO Danish Medicines Agency Says Type 2 Diabetes Patients Should Start Treatment With 'Cheaper' Drugs
        May 1 NVO Breakouts In Focus: Google Goes Wild As Tasty IPO Sets Up
        May 1 PRGO Perrigo declares $0.276 dividend
        May 1 NVO UPDATE 1-Novo Nordisk owner to invest $200 million in quantum computing startups
        May 1 NVO Denmark to restrict Ozempic, other GLP-1 drugs, to treat type 2 diabetes
        May 1 NVO Novo Nordisk owner to invest $200 million in quantum computing startups
        Apr 30 NVO Ozempic Maker Novo Nordisk Has Denmark’s Economy Hooked
        Apr 30 NVO Eli Lilly reports $2 billion from Mounjaro, Zepbound in Q1 2024
        Apr 30 NVO IBD Stock Of The Day Eli Lilly Surges After Weight-Loss Drug Obliterates Sales Views
        Apr 30 NVO Novo, Teva, AstraZeneca issued FTC warnings over ‘bogus’ patents
        Apr 30 NVO Update: FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications
        Apr 30 NVO Eli Lilly (LLY) Q1 Earnings Top, Sales Miss, 2024 View Raised
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Diabetes Diabetes Care Hormones Pharmaceutical Products Active Pharmaceutical Ingredients Allergy Analgesics Animal Health Anti Diabetic Drugs Biopharmaceutical Cough Dietary Supplement ETF Endocrine System Exchange Traded Fund Feminine Hygiene Gastrointestinal Generic Drug Glucagon Like Peptide 1 Growth Hormone
        Pharmaceuticals Segment

        Pharmaceuticals segment is a sector of the healthcare industry that focuses on the research, development, production, and marketing of drugs and other pharmaceutical products. This segment includes companies that manufacture and distribute prescription and over-the-counter drugs, as well as those that provide related services such as contract manufacturing and clinical research.

        Browse All Tags